Filing Flows

Filing Flows › ResMed (RMD) › Next earnings date

ResMed (RMD) earnings: beat the estimate

ResMed (RMD) reported on Oct 29, 2026 and beat the EPS estimate: $2.91 against $2.67 (+8.9%). Revenue was $1.4B for Q1 FY27, +6% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+8.9% vs estimate
Beat rate100%

The last report

ResMed reported revenue of $1.4B for the first quarter fiscal 2027 (+6% Y/Y), net earnings $418M: Total Sleep and Breathing Health $1.3B, Residential Care Software $155M. How it makes money → · Every quarter →

ResMed: EPS against the estimate, last 5 reportsResMed: EPS against the estimate, last 5 reportsEstimateReported$2.50$2.55Oct 25$2.72$2.81Jan 26$2.80$2.86Apr 26$2.89$2.95Aug 26$2.67$2.91Oct 26
Latest (Oct 26): Estimate $2.67, Reported $2.91.
RMD: the stock's move on each reportRMD: the stock's move on each reportAug 6, 2026-5.4%Apr 30, 2026-3.3%Jan 29, 2026+0.2%Oct 30, 2025-2.7%

ResMed's latest quarter

ResMed, Q1 FY27: revenue $1.4B (+6% year over year), operating margin 32.0%, net earnings $418M, operating cash flow $422M. The chart follows the revenue to costs, profit and cash.

Questions

Did ResMed beat earnings?

ResMed (RMD) reported on Oct 29, 2026 and beat the EPS estimate: $2.91 against $2.67 (+8.9%).

When does RMD report earnings?

The next date is not set yet.

Does ResMed usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.